L26/P-353 Should we continue screening for chronic endometritis? A retrospective analysis of more than 780 infertile patients undergoing hysteroscopy and endometrial biopsy
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.689 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von D.R. Kalaitzopoulos und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What is the prevalence of chronic endometritis (CE) and how do different treatment trajectories influence the clinical outcomes? Summary answer CE showed no association with IVF outcomes; antibiotic treatment did not improve live birth rates, questioning routine CE screening and empirical therapy. What is known already The identification of plasma cells (PCs) within endometrial tissue is a well-recognized indicator of CE. Despite this, universally-accepted criteria for CE diagnosis and severity remain undefined. Adding to the complexity of its detection, CE is often asymptomatic or presents with minimal symptoms, making its diagnosis particularly difficult. Consequently, correctly defining the prevalence of CE among infertile patients remains challenging. Furthermore, there is ongoing debate whether antibiotic treatment actually improves clinical outcomes in case of CE. Study design, size, duration Retrospective observational study at a university hospital (years:2020-2021 with 1-year follow-up). Overall, 786 women undergoing HSC and endometrial-biopsy. Among CE-positive patients, 104 underwent a control biopsy after antibiotic treatment. Reproductive outcomes were assessed in 585 women undergoing ≥1 embryo transfer and compared between CE-positive and CE-negative patients per first transfer and cumulatively at 1 year; additional sub-analyses were performed according to antibiotic treatment, number of treatment cycles, and whether a control biopsy was performed. Participants/materials, setting, methods CE was diagnosed based on PCs amount and tissue distribution according to a previously-validated histopathological scheme and classified as grades 0 (CE-negative), 1–3 (CE-positive, of progressive severity). Demographic characteristics, (median maternal age:35 years; median BMI:24 Kg/m2; ethnicity: Caucasian 82%/African 12%/Arab 4%/Asian 2%), previous endo-cavitary conditions and reproductive history (e.g., previous live-births, miscarriages, implantation failures) were tested as confounders on all outcomes. All patients underwent IVF/ICSI, and 585 underwent ≥1 cleavage/blastocyst, fresh/vitrified-warmed, untested/euploid, single/double embryo-transfer(s)(ET). Main results and the role of chance 38.6% (N = 304/786) of the patients were CE-positive (class-1:29%, classe-2/3:9.6%). CE positivity was significantly associated with a diagnosis of trophoblast-retention at hysteroscopy (OR = 3.5,95%CI:1.4-8.7,p=0.006), increasing number of previous miscarriages (OR = 1.2,95%CI:1-1.13,p=0.015) and Arab ethnicity (OR versus Caucasian=2.6,95%CI:1.2-5.4,p=0.011) while no other baseline characteristics were associated with CE. Reproductive outcomes were evaluated in 585 women undergoing ≥1 ET. Live birth rate (LBR) per first ET did not differ between CE-positive and CE-negative patients (N = 82/229,35.8% versus N = 123/356,34.6%) showing no statistically significant difference between the two groups (p = 0.310), nor did positive pregnancy test rate, biochemical pregnancy loss, miscarriage, ectopic pregnancy rate, or cumulative LBR within one year (CE-positive N = 127/229,55.5% versus CE-negative N = 200/356,56.2% p = 0.865). Among CE-positive patients, 92%(N = 281/304) received antibiotic treatment and 37%(N = 104/28) underwent a control biopsy; histological improvement was observed in 58%(N = 60/104), whereas 42%(N = 44/104) showed persistent CE. No difference was reported versus CE-negative patients across all outcomes. Only blastocyst-stage transfer and euploid ET, which were used to adjust the results, were independently associated with higher LBR. Limitations, reasons for caution Although this study reflects a large IVF-center’s real-life experience, its retrospective design and non-standardized management of CE limit the strength of the conclusions. Limited sample sizes in some subgroups, indication-based hysteroscopy, widespread treatment of CE-positive patients warrant caution. Moreover, a consensus on CE diagnosis is still missing. Wider implications of the findings This study encourages two future analyses: (i) a non-selection study to assess CE-positivity in the general IVF population and its impact on the clinical outcomes, and (ii) a randomized-controlled-trial to compare the outcomes in CE-positive patients undergoing or not undergoing antibiotic treatment. Trial registration number No
Zitieren
APA
Kalaitzopoulos, D., Petrone, P., Roy, C. V., Vaiarelli, A., Blockeel, C., Waelput, W., Cimadomo, D., & Mackens, S. (2026). L26/P-353 Should we continue screening for chronic endometritis? A retrospective analysis of more than 780 infertile patients undergoing hysteroscopy and endometrial biopsy. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.689
Vancouver
Kalaitzopoulos D, Petrone P, Roy CV, Vaiarelli A, Blockeel C, Waelput W, et al. L26/P-353 Should we continue screening for chronic endometritis? A retrospective analysis of more than 780 infertile patients undergoing hysteroscopy and endometrial biopsy. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.689
BibTeX
@article{Kalaitzopoulos2026,
author = {Kalaitzopoulos, D.R. and Petrone, P. and Roy, C. Van and Vaiarelli, A. and Blockeel, C. and Waelput, W. and Cimadomo, D. and Mackens, S.},
title = {L26/P-353 Should we continue screening for chronic endometritis? A retrospective analysis of more than 780 infertile patients undergoing hysteroscopy and endometrial biopsy},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.689}
}
EUVIMED